JE, B., VK, Y., J, Z., CS, C., IC, W., CW, S., & EW, C. (2022). Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong. Reviews in cardiovascular medicine, 23(10), 327. https://doi.org/10.31083/j.rcm2310327
Chicago Style (17th ed.) CitationJE, Blais, Yan VK, Zhao J, Chui CS, Wong IC, Siu CW, and Chan EW. "Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong." Reviews in Cardiovascular Medicine 23, no. 10 (2022): 327. https://doi.org/10.31083/j.rcm2310327.
MLA (9th ed.) CitationJE, Blais, et al. "Low-Density Lipoprotein Cholesterol Treatment Target Achievement in Patients with Myocardial Infarction, Percutaneous Coronary Intervention, or Stroke in Hong Kong." Reviews in Cardiovascular Medicine, vol. 23, no. 10, 2022, p. 327, https://doi.org/10.31083/j.rcm2310327.